跳至主要内容
临床试验/NCT06604013
NCT06604013已完成不适用

Class III Obesity and Periodontitis: Gingival Crevicular Fluid of Adiponectin and Resistin As Predictable Implement in Staging and Grading System and Effects of Periodontal Therapy

Al-Azhar University2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年9月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
adiponectin level in gingival crevicular fluid

研究概览

简要总结

The goal of this clinical trial is to evaluate the relationship between obesity and gingival crevicular fluid resistin and adiponectin in periodontitis patients as well as assess the effect of non-surgical periodontal therapy on their levels using ELISA in obese individuals. Researchers will compare different stages of periodontitis to see if degrees of inflammation and periodontal therapy related obesity

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • obese persons with Body Mass Index (BMI) more than 40 and suffering from periodontitis

排除标准

  • Patients receiving either antibiotics or non-steroidal anti- inflammatory at least 3 months prior to samples collection.
  • Patients subjected to previous periodontal therapy 6 months before sampling. Patients with systemic or local inflammatory conditions other than periodontal disease.
  • Neither lactating nor pregnant.

结局指标

主要结局

adiponectin level in gingival crevicular fluid

时间窗: From enrollment to the end of treatment results assessment at 12 weeks

resistin level in gingival crevicular fluid

时间窗: From enrollment to the end of treatment results assessment at 12 weeks

次要结局

  • O'Leary Plaque score(From enrollment to the end of treatment results assessment at 12 weeks)
  • bleeding on probing percentage (BoP)(From enrollment to the end of treatment results assessment at 12 weeks)
  • clinical attachment level (CAL)(From enrollment to the end of treatment results assessment at 12 weeks)
  • probing pocket depth(From enrollment to the end of treatment results assessment at 12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Asem Mohammed Kamel Ali

lecturer

Al-Azhar University

研究点 (2)

Loading locations...

相似试验